Portside Wealth Group LLC Has $173,000 Holdings in Haleon plc (NYSE:HLN)

Portside Wealth Group LLC trimmed its position in shares of Haleon plc (NYSE:HLN - Free Report) by 61.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,126 shares of the company's stock after selling 28,616 shares during the quarter. Portside Wealth Group LLC's holdings in Haleon were worth $173,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of HLN. Wellington Management Group LLP raised its position in Haleon by 67.5% in the 4th quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after buying an additional 6,175,835 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in Haleon in the 4th quarter valued at $45,110,000. Raymond James Financial Inc. purchased a new stake in Haleon in the 4th quarter valued at $42,193,000. FMR LLC raised its position in Haleon by 3.7% in the 4th quarter. FMR LLC now owns 108,827,814 shares of the company's stock valued at $1,038,217,000 after buying an additional 3,909,545 shares during the last quarter. Finally, Bank Julius Baer & Co. Ltd Zurich purchased a new stake in Haleon in the 4th quarter valued at $39,628,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently commented on HLN. BNP Paribas raised Haleon to a "strong-buy" rating in a research report on Tuesday, May 27th. BNP Paribas Exane raised Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a research report on Tuesday, May 27th. Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. HSBC reaffirmed a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Five investment analysts have rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $12.33.

Haleon Trading Down 0.4%

Shares of Haleon stock opened at $11.07 on Friday. The stock has a fifty day moving average price of $10.50 and a 200-day moving average price of $10.03. Haleon plc has a 1 year low of $8.25 and a 1 year high of $11.42. The firm has a market cap of $49.84 billion, a PE ratio of 32.56, a P/E/G ratio of 2.82 and a beta of 0.31. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.